• New Study Shows Links Between Stress and Disability/Relapses in MS
    Thursday, May 25, 2023 from National MS Society All News
    /About-the-Society/News/New-Study-Shows-Links-Between-Stress-and-Disabilit
  • Global Summit Reviews Advances and Opportunities for Strategic Collaborations to Speed Pathways to M
    Tuesday, May 23, 2023 from National MS Society All News
    /About-the-Society/News/Global-Summit-Reviews-Advances-and-Opportunities-f
  • aHSCT Shows Effectiveness When Compared with Three Other MS Therapies in Novel Study
    Friday, May 19, 2023 from National MS Society All News
    /About-the-Society/News/aHSCT-Shows-Effectiveness-When-Compared-with-Three
  • New Research: How EBV May Trigger MS
    Friday, May 19, 2023 from National MS Society All News
    /About-the-Society/News/New-Research-How-EBV-May-Trigger-MS
  • Medicare Covers Seat Elevation for Medicare Beneficiaries Using Power Wheelchairs
    Thursday, May 18, 2023 from National MS Society All News
    /About-the-Society/News/Medicare-Covers-Seat-Elevation-for-Medicare-Benefi
  • “Comorbid” Conditions Appear in People with MS at Diagnosis, but May Not be Treated, Says New Study
    Monday, May 15, 2023 from National MS Society All News
    /About-the-Society/News/Comorbid”-Conditions-Appear-in-People-with-MS-at-D
  • Research Study Highlights that Multiple Sclerosis Can Be Prevalent in Any Population in the United S
    Monday, May 15, 2023 from National MS Society All News
    /About-the-Society/News/Research-Study-Highlights-that-Multiple-Sclerosis
  • MS Activists Return to In-person MS State Action Days
    Wednesday, May 10, 2023 from National MS Society All News
    /About-the-Society/News/MS-Activists-Return-to-Capitals-for-MS-State-Actio
  • Studies on MS diets, stem cells and health disparities are among those reported at the AAN meeting
    Wednesday, May 3, 2023 from National MS Society All News
    /About-the-Society/News/Studies-on-MS-diets,-stem-cells-and-health-dispari
  • MS Trial Alert: Investigators Recruiting Nationwide – Can an Internet Program for Behavior Change Im
    Monday, May 1, 2023 from National MS Society All News
    /About-the-Society/News/MS-Trial-Alert-Investigators-Recruiting-Nation-(1)
  • News on Mediterranean diet, stem cells and treatment benefits before MS diagnosis are among studies
    Wednesday, April 19, 2023 from National MS Society All News
    /About-the-Society/News/News-on-Mediterranean-diet-and-treatment-benefits
  • First Generic Versions of Aubagio® (teriflunomide) Now Available
    Tuesday, April 18, 2023 from National MS Society All News
    /About-the-Society/News/First-Generic-Versions-of-Aubagio®-(teriflunomide)
  • National Multiple Sclerosis Society Recognizes National Sponsors of Bike MS® 2023
    Tuesday, April 18, 2023 from National MS Society All News
    /About-the-Society/News/National-Multiple-Sclerosis-Society-Recognizes-Nat
  • Victory in North Carolina: Medicaid Expansion Signed into Law
    Thursday, April 13, 2023 from National MS Society All News
    /About-the-Society/News/Victory-in-North-Carolina-Medicaid-Expansion-Signe
  • 31 Patient and Provider Groups Warn that Mifepristone Ruling Threatens All FDA-approved Drugs
    Tuesday, April 11, 2023 from National MS Society All News
    /About-the-Society/News/31-Patient-and-Provider-Groups-Warn-that-Mifeprist
  • EBV-Autoimmune disease treatment that could expand overall MS treatment program options
    Sunday, April 9, 2023 from MS Views & News
    by Alan M Dattner, MD     doctordattner@gmail.com   I was excited to see the studies that showed a 32-fold increase in MS in recruits who became Epstein-Barr virus (EBV) positive [i] . Howard Weiner, MD at...
  • Noted MS Neurologist Dr. Roland Martin Wins 2023 John Dystel Prize for Multiple Sclerosis Research
    Friday, April 7, 2023 from National MS Society All News
    /About-the-Society/News/Noted-MS-Neurologist-Dr-Roland-Martin-Wins-2023-Jo
  • New Study: Sexual Function and Satisfaction May be Low and Linked to Other Symptoms in People with M
    Monday, April 3, 2023 from National MS Society All News
    /About-the-Society/News/New-Study-Sexual-Function-and-Satisfaction-May-be
  • Cycle Pharmaceuticals to launch TASCENSO ODT® (fingolimod) in US in Q1 2023
    Saturday, March 25, 2023 from MS Views & News
    Eligible patients will receive full MS patient support program through Cycle Vita™
  • U.S. Representatives Michael Burgess and Lori Trahan Announced as House of Representatives Co-Chairs
    Friday, March 24, 2023 from National MS Society All News
    /About-the-Society/News/U-S-Representatives-Michael-Burgess-and-Lori-Traha
  • Children at risk of multiple sclerosis often go undetected in early stages
    Thursday, March 16, 2023 from Multiple Sclerosis Research News -- ScienceDaily
    Criteria used by neurologists to assess for multiple sclerosis (MS) in adults may fail to identify the illness in children with imaging suspicious for the disease, an oversight that could delay treatment of the disease at its earliest...
  • Society-Funded Study Helps People with MS to Increase and Sustain Physical Activity with Website and
    Thursday, March 16, 2023 from National MS Society All News
    /About-the-Society/News/Society-Funded-Study-Helps-People-with-MS-to-Incre
  • New Study Finds No Increase in MS Relapses After Fertility Treatments
    Wednesday, March 15, 2023 from National MS Society All News
    /About-the-Society/News/New-Study-Finds-No-Increase-in-MS-Relapses-After-F
  • First nasal monoclonal antibody treatment for COVID-19 shows promise for treating virus, other diseases
    Wednesday, March 8, 2023 from Multiple Sclerosis Research News -- ScienceDaily
    A pilot trial tested the nasal administration of the drug Foralumab, an anti-CD3 monoclonal antibody. Investigators found evidence that the drug dampened the inflammatory T cell response and decreased lung inflammation in patients with...
  • Research on Pathways to Cures Highlighted at ACTRIMS Forum
    Tuesday, March 7, 2023 from National MS Society All News
    /About-the-Society/News/Research-on-Pathways-to-Cures-Highlighted-at-ACTRI
  • Researchers Report Another Possible Trigger for MS
    Thursday, March 2, 2023 from National MS Society All News
    /About-the-Society/News/Researchers-Report-Another-Possible-Trigger-for-MS
  • Medicare Proposes Benefit Expansion for Seat Elevation Equipment on Power Wheelchairs
    Thursday, March 2, 2023 from National MS Society All News
    /About-the-Society/News/Medicare-Proposes-Benefit-Expansion-for-Seat-Eleva
  • MS Society Endorses Air Carrier Access Amendments Act of 2023
    Thursday, March 2, 2023 from National MS Society All News
    /About-the-Society/News/MS-Society-Endorses-Air-Carrier-Access-Amendments
  • FDA Approves Tascenso ODT® (fingolimod), similar to Gilenya, for Relapsing MS
    Tuesday, February 21, 2023 from National MS Society All News
    /About-the-Society/News/FDA-Approves-Tascenso-ODT®-(fingolimod),-similar-t
  • National MS Society Recognizes National Sponsors of Walk MS®
    Monday, February 13, 2023 from National MS Society All News
    /About-the-Society/News/National-MS-Society-Recognizes-National-Sponso-(1)
  • New Study Shows How Primary Progressive MS May Differ from Other Forms of MS
    Thursday, February 9, 2023 from National MS Society All News
    /About-the-Society/News/New-Study-Shows-How-Primary-Progressive-MS-May-Dif
  • Researcher takes another step toward discovering how a brain molecule could halt MS
    Wednesday, February 1, 2023 from Multiple Sclerosis Research News -- ScienceDaily
    A researcher is one step closer to demonstrating the potential of a brain molecule called fractalkine to halt and even reverse the effects of multiple sclerosis and other neurodegenerative diseases. Researchers injected fractalkine into...
  • New Research Shows Link Between Sleep and Thinking Problems in People with MS
    Tuesday, January 31, 2023 from National MS Society All News
    /About-the-Society/News/New-Research-Shows-Link-Between-Sleep-and-Thinking
  • New Study Shows Opioid Prescriptions Higher in People with MS
    Friday, January 27, 2023 from National MS Society All News
    /About-the-Society/News/New-Study-Shows-Opioid-Prescriptions-Higher-in-Peo
  • National Multiple Sclerosis Society Awards Dr. Ruth Ann Marrie Barancik Prize for Innovation in MS R
    Friday, January 27, 2023 from National MS Society All News
    /About-the-Society/News/National-Multiple-Sclerosis-Society-Awards-Dr-Ruth
  • Conference Focuses on Improving MS Therapy Trials to Speed Cures for Everyone
    Tuesday, January 24, 2023 from National MS Society All News
    /About-the-Society/News/Conference-Focuses-on-Improving-MS-Therapy-Trials
  • Investigators in Italy Report Stem Cell Injections Safe and Showed Hints of Benefit in Progressive M
    Thursday, January 12, 2023 from National MS Society All News
    /About-the-Society/News/Investigators-in-Italy-Report-Stem-Cell-Injections
  • National MS Society Commits Nearly $8 Million for Targeted Research to Drive Pathways to Cures
    Tuesday, January 10, 2023 from National MS Society All News
    /About-the-Society/News/National-MS-Society-Commits-Nearly-$8-Million-for
  • Less Physical Activity Linked to Signs of Worsening MS, Says New Study Funded by National MS Society
    Friday, January 6, 2023 from National MS Society All News
    /About-the-Society/News/Less-Physical-Activity-Linked-to-Signs-of-Worsenin
  • FDA Approves Briumvi™ (ublituximab-xiiy) for Relapsing MS
    Wednesday, December 28, 2022 from National MS Society All News
    /About-the-Society/News/FDA-Approves-Briumvi™-(ublituximab)-for-Relapsing
  • To Tell or Not to Tell? New Study Offers Insights into Tough Decisions About Disclosing Diagnosis of
    Thursday, December 22, 2022 from National MS Society All News
    /About-the-Society/News/To-Tell-or-Not-to-Tell-New-Study-Offers-Insights-i
  • Congress Passes Omnibus Bill – Includes MS Priorities
    Thursday, December 22, 2022 from National MS Society All News
    /About-the-Society/News/Congress-Passes-Omnibus-Bill-–-Includes-MS-Priorit
  • Stem cell transplants may delay disability longer than some MS medications
    Wednesday, December 21, 2022 from Multiple Sclerosis Research News -- ScienceDaily
    In people with active secondary progressive multiple sclerosis (MS), hematopoietic stem cell transplants may delay disability longer than some other MS medications, according to a new study. The study involved autologous hematopoietic...
  • Study from Italy Suggests Some People with Active Secondary Progressive MS May Benefit from Bone Mar
    Wednesday, December 21, 2022 from National MS Society All News
    /About-the-Society/News/Study-from-Italy-Suggests-Some-People-with-Active
  • What Triggers Changes in Gut Bacteria in People with MS? New Study Suggests Pathway
    Monday, December 19, 2022 from National MS Society All News
    /About-the-Society/News/What-Triggers-Changes-in-Gut-Bacteria-in-People-wi
  • MS Treatment Extends Time to First Symptom in Trial in People with Radiologically Isolated Syndrome
    Thursday, December 15, 2022 from National MS Society All News
    /About-the-Society/News/MS-Treatment-Extends-Time-to-First-Symptom-in-Tria
  • Light therapy relieves fatigue syndrome in Multiple Sclerosis
    Monday, December 12, 2022 from Multiple Sclerosis Research News -- ScienceDaily
    Multiple Sclerosis (MS) is almost always accompanied by fatigue, a massive tiredness that is described by the vast majority of patients as the most distressing symptom. In a recent scientific study, a research group identified light...
  • Respect for Marriage Act – What It Means for the MS Community
    Friday, December 9, 2022 from National MS Society All News
    /About-the-Society/News/Respect-for-Marriage-Act
  • Patient Groups Urge U.S. District Court to Preserve Preventive Services Coverage Requirement
    Wednesday, December 7, 2022 from National MS Society All News
    /About-the-Society/News/Patient-Groups-Urge-U-S-District-Court-to-Preserve
  • New York Passes Legislation to Protect Patients with Medical Debt
    Wednesday, December 7, 2022 from National MS Society All News
    /About-the-Society/News/New-York-Passes-Legislation-to-Protect-Patients-wi
    • Powered by Feed Informer